Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00544076 · ClinicalTrials.gov registry record · Phase 3
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer
A Phase 3 study, sponsored by City of Hope Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 110
- Enrollment target
NCT00544076 is a Phase 3 study that was terminated before completion, run by City of Hope Medical Center. The registered enrollment target is 110 participants.
The verdict
NCT00544076, a Phase 3 study, was terminated before completion, sponsored by City of Hope Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 110 participants
- Enrollment target
Study Summary
RATIONALE: Sildenafil citrate and alprostadil may help patients who have undergone prostatectomy for prostate cancer to recover from erectile dysfunction. PURPOSE: This randomized clinical trial is studying giving sildenafil together with alprostadil in treating patients undergoing nerve-sparing robotic-assisted radical prostatectomy for nonmetastatic prostate cancer.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- DRUG sildenafil citrate
- DRUG alprostadil
- PROCEDURE robotic-assisted laparoscopic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00544076
The ClinicalTrials.gov registry entry for NCT00544076 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00544076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00544076 about?
NCT00544076 is a clinical study titled "ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer". RATIONALE: Sildenafil citrate and alprostadil may help patients who have undergone prostatectomy for prostate cancer to recover from erectile dysfunction. PURPOSE: This randomized clinical trial is studying giving sildenafil together with alprostadil in treating patients undergoing nerve-sparing ro...
What is the current status of trial NCT00544076?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 110 participants. The study started on 2006-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00544076?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), sildenafil citrate (DRUG), alprostadil (DRUG), robotic-assisted laparoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00544076?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.